Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Jogdand, Prajakta S ^a   Singh, Susheel K ^a   Christiansen, Michael ^b   Dziegiel, Morten H ^c   Singh, Subhash ^d   Theisen, Michael ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Antibody dependent cellular inhibition assay; GLURP; Mitotracker Red CMXRos; Plasmodium falciparum

Indexed keywords

DYE; IMMUNOGLOBULIN G; MITOTRACKER RED CMXROS; UNCLASSIFIED DRUG; MALARIA VACCINE; ORGANIC COMPOUND; PROTOZOON ANTIBODY; RED DYE CMXROS;

ANTIBODY DEPENDENT CELLULAR INHIBITION ASSAY; ARTICLE; ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MICROBIOLOGICAL PARAMETERS; MITOCHONDRION; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PROCESS OPTIMIZATION; RELIABILITY; REPRODUCIBILITY; STAINING; BLOOD; CELLULAR IMMUNITY; COMPARATIVE STUDY; EVALUATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIAL VIABILITY; PARASITE LOAD;

ANTIBODIES, PROTOZOAN; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MALARIA VACCINES; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; ORGANIC CHEMICALS; PARASITE LOAD; PLASMODIUM FALCIPARUM; STAINING AND LABELING;

EID: 84865259103     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-235     Document Type: Article

References (53)

1. In vivo veritas: lessons from immunoglobulin-transfer experiments in malaria patients. Druilhe P, Sabchareon A, Bouharoun-Tayoun H, Oeuvray C, Perignon JL, Ann Trop Med Parasitol 1997 91 Supp 37 53
2. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P, J Exp Med 1990 172 1633 1641
3. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. Roussilhon C, Oeuvray C, Muller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P, PLoS Med 2007 4 320
4. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Bouharoun-Tayoun H, Druilhe P, Infect Immun 1992 60 1473 1481
5. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P, J Exp Med 1995 182 409 418
6. A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, Druilhe PL, J Immunol 2007 178 3099 3106 (Pubitemid 46333191)
7. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Shi YP, Udhayakumar V, Oloo AJ, Nahlen BL, Lal AA, AmJTrop Med Hyg 1999 60 135 141 (Pubitemid 29066018)
8. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M, Filgueira MC, Tartar A, Druilhe P, Blood 1994 84 1594 1602 (Pubitemid 24273030)
9. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Theisen M, Soe S, Oeuvray C, Thomas AW, Vuust J, Danielsen S, Jepsen S, Druilhe P, Infect Immun 1998 66 11 17 (Pubitemid 28018795)
10. A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. Druilhe P, Spertini F, Soesoe D, Corradin G, Mejia P, Singh S, Audran R, Bouzidi A, Oeuvray C, Roussilhon C, PLoS Med 2005 2 344
11. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Hermsen CC, Verhage DF, Telgt DS, Teelen K, Bousema JT, Roestenberg M, Bolad A, Berzins K, Corradin G, Leroy O, Theisen M, Sauerwein RW, Vaccine 2007 25 2930 2940 (Pubitemid 46412561)
12. A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children. Belard S, Issifou S, Hounkpatin AB, Schaumburg F, Ngoa UA, Esen M, Fendel R, de Salazar PM, Murbeth RE, Milligan P, Imbault N, Imoukhuede EB, Theisen M, Jepsen S, Noor RA, Okech B, Kremsner PG, Mordmuller B, PLoS One 2011 6 22525
13. Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate. Esen M, Kremsner PG, Schleucher R, Gassler M, Imoukhuede EB, Imbault N, Leroy O, Jepsen S, Knudsen BW, Schumm M, Knobloch J, Theisen M, Mordmuller B, Vaccine 2009 27 6862 6868
14. Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon. Mordmuller B, Szywon K, Greutelaers B, Esen M, Mewono L, Treut C, Murbeth RE, Chilengi R, Noor R, Kilama WL, Imoukhuede EB, Imbault N, Leroy O, Theisen M, Jepsen S, Milligan P, Fendel R, Kremsner PG, Issifou S, Vaccine 2010 28 6698 6703
15. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Theisen M, Soe S, Brunstedt K, Follmann F, Bredmose L, Israelsen H, Madsen SM, Druilhe P, Vaccine 2004 22 1188 1198 (Pubitemid 38296662)
16. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 (Pubitemid 10082023)
17. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Makler MT, Hinrichs DJ, AmJTrop Med Hyg 1993 48 205 210 (Pubitemid 23083736)
18. Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency. Maguire JD, Lederman ER, Barcus MJ, O'Meara WA, Jordon RG, Duong S, Muth S, Sismadi P, Bangs MJ, Prescott WR, Baird JK, Wongsrichanalai C, Malar J 2006 5 92
19. Editorial: 100years ago: Giemsa's solution for staining of plasmodia. Fleischer B, Trop Med Int Health 2004 9 755 756 (Pubitemid 38962001)
20. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. Milne LM, Kyi MS, Chiodini PL, Warhurst DC, J Clin Pathol 1994 47 740 742
21. Automated flow cytometric analysis of drug susceptibility of malaria parasites. van Vianen PH, Thaithong S, Reinders PP, van Engen A, van der Keur M, Tanke HJ, van der Kaay HJ, Mons B, AmJTrop Med Hyg 1990 43 602 607
22. Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer. Izumiyama S, Omura M, Takasaki T, Ohmae H, Asahi H, Exp Parasitol 2009 121 144 150
23. A flow cytometry-based assay for measuring invasion of red blood cells by Plasmodium falciparum. Bei AK, Desimone TM, Badiane AS, Ahouidi AD, Dieye T, Ndiaye D, Sarr O, Ndir O, Mboup S, Duraisingh MT, Am J Hematol 2010 85 234 237
24. An adaptable two-color flow cytometric assay to quantitate the invasion of erythrocytes by Plasmodium falciparum parasites. Theron M, Hesketh RL, Subramanian S, Rayner JC, Cytometry A 2010 77 1067 1074
25. Thiazole orange: a new dye for Plasmodium species analysis. Makler MT, Lee LG, Recktenwald D, Cytometry 1987 8 568 570 (Pubitemid 18076902)
26. Rapid identification and detection of parasitized human red cells by automated flow cytometry. Whaun JM, Rittershaus C, Ip SH, Cytometry 1983 4 117 122
27. Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Staalsoe T, Giha HA, Dodoo D, Theander TG, Hviid L, Cytometry 1999 35 329 336 (Pubitemid 29160231)
28. Use of hydroethidine and flow cytometry to assess the effects of leukocytes on the malarial parasite Plasmodium falciparum. van der Heyde HC, Elloso MM, vande Waa J, Schell K, Weidanz WP, Clin Diagn Lab Immunol 1995 2 417 425
29. Double staining of Plasmodium falciparum nucleic acids with hydroethidine and thiazole orange for cell cycle stage analysis by flow cytometry. Jouin H, Daher W, Khalife J, Ricard I, Puijalon OM, Capron M, Dive D, Cytometry A 2004 57 34 38 (Pubitemid 38055712)
30. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Jimenez-Diaz MB, Mulet T, Gomez V, Viera S, Alvarez A, Garuti H, Vazquez Y, Fernandez A, Ibanez J, Jimenez M, Gargallo-Viola D, Angulo-Barturen I, Cytometry A 2009 75 225 235
31. Culture of malaria parasites in two different red blood cell populations using biotin and flow cytometry. Pattanapanyasat K, Yongvanitchit K, Heppner DG, Tongtawe P, Kyle DE, Webster HK, Cytometry 1996 25 287 294 (Pubitemid 26386326)
32. Mitochondrial membrane potential in living cells. Chen LB, Annu Rev Cell Biol 1988 4 155 181 (Pubitemid 19139255)
33. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB, Proc Natl Acad Sci U S A 1991 88 3671 3675 (Pubitemid 21916685)
34. Fluorescent labeling of mitochondria. Chen LB, Methods Cell Biol 1989 29 103 123
35. Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria. Modica-Napolitano JS, Weiss MJ, Chen LB, Aprille JR, Biochem Biophys Res Commun 1984 118 717 723
36. Inhibition of an oligomycin-sensitive ATPase by cationic dyes, some of which are atypical uncouplers of intact mitochondria. Mai MS, Allison WS, Arch Biochem Biophys 1983 221 467 476 (Pubitemid 13135508)
37. Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, Haugland RP, J Histochem Cytochem 1996 44 1363 1372
38. Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Pendergrass W, Wolf N, Poot M, Cytometry A 2004 61 162 169 (Pubitemid 39362290)
39. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, Lal AA, J Infect Dis 2001 184 107 111 (Pubitemid 32568509)
40. Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth. Pratt-Riccio LR, Bianco C, Totino PR, Perce-Da-Silva Dde S, Silva LA, Riccio EK, Ennes-Vidal V, Neves-Ferreira AG, Perales J, Da Rocha SL, Dias-Da-Silva F, Ferreira-da-Cruz MF, Daniel-Ribeiro CT, De Oliveira-Ferreira J, Theisen M, Carvalho LJ, Banic DM, Mem Inst Oswaldo Cruz 2011 106 Suppl 1 34 43
41. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675
42. Synchronization of Plasmodium falciparum erythrocytic stages in culture. Lambros C, Vanderberg JP, J Parasitol 1979 65 418 420 (Pubitemid 10222999)
43. Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Jensen JB, AmJTrop Med Hyg 1978 27 1274 1276 (Pubitemid 9080453)
44. The progression of the intra-erythrocytic cell cycle of Plasmodium falciparum and the role of the centriolar plaques in asynchronous mitotic division during schizogony. Arnot DE, Ronander E, Bengtsson DC, Int J Parasitol 2011 41 71 80
45. A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2-a GLURP-MSP3 fusion protein malaria vaccine candidate. Lousada-Dietrich S, Jogdand PS, Jepsen S, Pinto VV, Ditlev SB, Christiansen M, Larsen SO, Fox CB, Raman VS, Howard RF, Vedvick TS, Ireton G, Carter D, Reed SG, Theisen M, Vaccine 2011 29 3284 3292
46. Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Biggar RJ, Christiansen M, Rostgaard K, Smedby KE, Adami HO, Glimelius B, Hjalgrim H, Melbye M, Int J Cancer 2009 124 2616 2620
47. Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Tebo AE, Kremsner PG, Luty AJ, Exp Parasitol 2001 98 20 28 (Pubitemid 32612590)
48. Identification of a major linear B cell epitope of the Plasmodium falciparum Glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Theisen M, Soe S, Jessing S, Okkels L, Danielsen S, Oeuvray C, Druilhe P, Jepsen S, Vaccine 2000 19 204 212 (Pubitemid 30621513)
49. Human malarial disease: a consequence of inflammatory cytokine release. Clark IA, Budd AC, Alleva LM, Cowden WB, Malar J 2006 5 85
50. Dendritic cell-dependent inhibition of B cell proliferation requires CD22. Santos L, Draves KE, Boton M, Grewal PK, Marth JD, Clark EA, J Immunol 2008 180 4561 4569
51. A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases. Ch'ng JH, Kotturi SR, Chong AG, Lear MJ, Tan KS, Cell Death Dis 2010 1 26
52. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. Srivastava IK, Rottenberg H, Vaidya AB, J Biol Chem 1997 272 3961 3966 (Pubitemid 27078454)
53. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Srivastava IK, Vaidya AB, Antimicrob Agents Chemother 1999 43 1334 1339 (Pubitemid 29259321)